trending Market Intelligence /marketintelligence/en/news-insights/trending/gI4moMasS09EjAoW9erIrA2 content esgSubNav
In This List

Harrow Health to sell subsidiary's assets to Noice for $8M

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Harrow Health to sell subsidiary's assets to Noice for $8M

Harrow Health Inc. agreed to sell all assets of its wholly owned unit Park Compounding Inc. that are related to the compounding business of pharmaceuticals not used for eye care to Noice Rx LLC for $8 million.

Under the deal, Harrow Health will issue Noice an $8 million note at an annual interest of 9.5%. In turn, Noice will make 96 monthly cash payments to Harrow Health over an eight-year period after the closing.

Harrow Health will also receive a warrant that can be exercised after five years to own a 20% stake in Noice.

Harrow Health expects to close the transaction on or before Aug. 27, subject to closing conditions including a temporary pharmacy and sterile license permit from the California State Board of Pharmacy.